YouTube - Understanding Partial Seizures (Epilepsy #3)
Links shared publicly online about this topic.
- 2,171total visits
YouTube - Understanding Partial Seizures (Epilepsy #3)
View full resource at youtube.com
Tags: Brain, Seizure, Epilepsy
Most Recently Shared on March 22, 2009 at 7:00 pm By:
Understanding Partial Seizures (Epilepsy #3) http://tinyurl.com/dy2spy
Seizure drug Keppra approved for children under 4 - Related Stories - AAP SmartBrief
smartbrief.com — “UCB's Keppra, an adjunctive epilepsy medicine, was approved by the FDA for use in children ages 1 month to 3 years. The agency based the expanded approval on a clinical finding that Keppra cuts the frequency of partial-onset seizures by at least 50% in this age group. ” View full resource at smartbrief.com
Most Recently Shared on January 29, 2012 at 12:00 am By:
Clara Song Physician, Doctor, and Pediatrician
Seizure drug Keppra approved for children under 4 http://t.co/H5tG1WZF
ingentaconnect Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with ...
ingentaconnect.com — “ingentaconnect Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with ...” View full resource at ingentaconnect.com
Most Recently Shared on September 26, 2011 at 5:06 am By:
Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with Epilepsy: (Source: CNS Drugs) http://t.co/PB9Wp1QV
Potiga (ezogabine) Tablets Approved For Seizure In Adults As Add-On Medication
medicalnewstoday.com — “The US Food and Drug Administration (FDA) has approved anticonvulsant Potiga (ezogabine) tablets as an add-on drug for the treatment of partial seizures in adults with epilepsy. The active ingredi” View full resource at medicalnewstoday.com
Most Recently Shared on June 14, 2011 at 12:05 am By:
Potiga (ezogabine) Tablets Approved For Seizure In Adults As Add-On Medication http://mnt.to/3X7h #epilepsy
Medical News: Epilepsy Drug Gets Nod but Marketing Is Delayed - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the anti-epilepsy drug ezogabine (Potiga) as an add-on treatment for patients 18 and older with partial-onset seizures, recommending that it be listed as a controlle” View full resource at medpagetoday.com
Most Recently Shared on June 13, 2011 at 4:53 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday Epilepsy Drug Gets Nod but Marketing Is Delayed http://bit.ly/m3WK5d #medical #Health
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy
medicalnewstoday.com — “GlaxoSmithKline has today launched Trobalt® (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with partial-onset seizures, and demonstrat” View full resource at medicalnewstoday.com
Most Recently Shared on May 17, 2011 at 11:05 am By:
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control E... http://mnt.to/3VXs
GSK's epilepsy drug Lamictal XR gets wider FDA approval - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA approved GlaxoSmithKline's Lamictal XR as monotherapy for partial seizures in patients age 13 and older. Lamictal XR is available as an add-on medicine for this indication as well as primary generalized tonic-clonic seizures. ” View full resource at smartbrief.com
Most Recently Shared on April 29, 2011 at 1:04 pm By:
Clara Song Physician, Doctor, and Pediatrician
GSK's epilepsy drug Lamictal XR gets wider FDA approval http://sbne.ws/r/7qr3
Perampanel Add-On Reduces Partial-Onset Seizures - QualityPoint Technologies
qualitypointtech.net — “New phase 3 results testing a higher dose of the drug suggest efficacy and safety in refractory epilepsy. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on April 14, 2011 at 2:00 am By:
Perampanel Add-On Reduces Partial-Onset Seizures: New phase 3 results testing a higher dose of the drug suggest ef... http://bit.ly/dI6osU
Eisai to seek marketing authorization for perampanel in the U.S. and EU
news-medical.net — “Eisai announced today that it will submit Marketing Authorization Applications in the United States and the European Union for the investigational compound perampanel (E2007) based on the results of three Phase III pivotal studies. Perampanel is a first-in-class, highly selective non-competitive AMPA-type glutamate receptor antagonist, discovered and being developed by Eisai for adjunctive treatment of partial onset seizures in patients with epilepsy.” View full resource at news-medical.net
Most Recently Shared on January 25, 2011 at 12:18 pm By:
Epilepsy News: Eisai to seek marketing authorization for perampanel in the U.S. and EU: Eisai announced today th... http://bit.ly/f4d8D3
New Clinical Trial Involves People With Epilepsy Who Still Get Seizures
medicalnewstoday.com — “Of the more than 3 million people with epilepsy in the U.S., two-thirds eventually gain partial or complete control of their seizures, while others continue to have seizures regularly despite taki” View full resource at medicalnewstoday.com
Most Recently Shared on December 14, 2010 at 1:05 pm By:
New Clinical Trial Involves People With Epilepsy Who Still Get Seizures http://mnt.to/3NZz #epilepsy
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures
medicalnewstoday.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial” View full resource at medicalnewstoday.com
Most Recently Shared on October 4, 2010 at 3:05 pm By:
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures http://mnt.to/3KJ7 #epilepsy
Eisai Announces Positive Results Of Phase III Trial For Perampanel In Epilepsy
medicalnewstoday.com — “Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, Eisai) announced that results of a Phase III study in epilepsy patients with refractory partial seizures demonstrate the clini” View full resource at medicalnewstoday.com
Most Recently Shared on August 25, 2010 at 5:00 pm By:
Eisai Announces Positive Results Of Phase III Trial For Perampanel In Epilepsy http://mnt.to/3HQ6 #epilepsy
Phase 3 study of perampanel for the treatment of epilepsy - MPR
empr.com — “Eisai announced results from its Phase 3 study of perampanel for the treatment of partial seizures in patients with epilepsy” View full resource at empr.com
Most Recently Shared on August 24, 2010 at 3:04 pm By:
MPR News: Phase 3 study of perampanel for the treatment of epilepsy: Eisai announced results from its Phase 3 stud... http://bit.ly/bK0jly
Phase 3 study of perampanel for the treatment of epilepsy - ONA
oncologynurseadvisor.com — “Eisai announced results from its Phase 3 study of perampanel for the treatment of partial seizures in patients with epilepsy” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 24, 2010 at 2:33 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Phase 3 study of perampanel for the treatment of epilepsy http://goo.gl/fb/dDgAS
Eisai Announces Positive Phase III Trial Results for Perampanel in Partial Epilepsy | Pharmaceutical Processing
pharmpro.com — “Eisai today announced the results of a Phase III study for the investigational compound perampanel (E2007), a first-in-class, highly selective non-competitive AMPA-type glutamate receptor antagonist, discovered by Eisai and under development for adjunctive treatment of partial seizures in patients with epilepsy.” View full resource at pharmpro.com
Most Recently Shared on August 24, 2010 at 12:40 pm By:
RT @PharmProEditor: Eisai Announces Positive Phase III Trial Results for Perampanel in Partial Epilepsy. http://bit.ly/dsfeQ3
Presurgical Evaluation of Medically Intractable Epilepsy: eMedicine Neurology
emedicine.medscape.com — “Overview: Medical Intractability Approximately 0.5-0.9% of the US population (ie, 3 million people) have been diagnosed with epilepsy. Half of these patients have partial seizures, and in 30%, seizures are not controlled adequately with antiepileptic drugs (AEDs). A conservative ...” View full resource at emedicine.medscape.com
Most Recently Shared on August 20, 2010 at 9:18 pm By:
Medscape Neurology Neurology and Health Site
Presurgical Evaluation of Medically Intractable Epilepsy: http://bit.ly/a8HbtE
Advertisement
